1. Home
  2. TMCI vs EBS Comparison

TMCI vs EBS Comparison

Compare TMCI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

N/A

Current Price

$4.81

Market Cap

279.6M

Sector

Health Care

ML Signal

N/A

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$6.21

Market Cap

312.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMCI
EBS
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.6M
312.8M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
TMCI
EBS
Price
$4.81
$6.21
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$4.77
$12.00
AVG Volume (30 Days)
358.7K
1.6M
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.83
EPS
N/A
N/A
Revenue
$212,690,000.00
$742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
$8.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.59
N/A
52 Week Low
$1.17
$4.36
52 Week High
$7.42
$14.06

Technical Indicators

Market Signals
Indicator
TMCI
EBS
Relative Strength Index (RSI) 57.17 51.64
Support Level $3.84 $4.36
Resistance Level $4.85 $8.59
Average True Range (ATR) 0.25 0.31
MACD 0.00 0.23
Stochastic Oscillator 73.68 75.12

Price Performance

Historical Comparison
TMCI
EBS

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: